
InsideDNA helps biotech and pharmaceutical companies speed up drug discovery with AI and genomics. Its proprietary analytics platform uses statistics, bioinformatics, and machine learning to analyze large genomics and metagenomics data for target discovery and patient stratification. It enables biomarker discovery, clinical trial risk reduction, and re-targeting of existing compound libraries. The product is a B2B platform serving pre-clinical and clinical programs with a focus on metagenomics and metatranscriptomics analysis. Customers include industrial and academic partners, with core data integrations to common genetic datasets and omics workflows.

InsideDNA helps biotech and pharmaceutical companies speed up drug discovery with AI and genomics. Its proprietary analytics platform uses statistics, bioinformatics, and machine learning to analyze large genomics and metagenomics data for target discovery and patient stratification. It enables biomarker discovery, clinical trial risk reduction, and re-targeting of existing compound libraries. The product is a B2B platform serving pre-clinical and clinical programs with a focus on metagenomics and metatranscriptomics analysis. Customers include industrial and academic partners, with core data integrations to common genetic datasets and omics workflows.